» Articles » PMID: 22771609

Variations in the Occurrence of Specific RpoB Mutations in Rifampicin-resistant Mycobacterium Tuberculosis Isolates from Patients of Different Ethnic Groups in Kuwait

Overview
Specialty General Medicine
Date 2012 Jul 10
PMID 22771609
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Objectives: Frequency of resistance-conferring mutations vary among isoniazid- and ethambutol-resistant Mycobacterium tuberculosis isolates obtained from patients of various ethnic groups. This study was aimed to determine the occurrence of specific rpoB mutations in rifampicin-resistant M. tuberculosis isolates from tuberculosis patients of various ethnic groups in Kuwait.

Methods: Rifampicin-resistant M. tuberculosis isolates (n=119) from South Asian (n=55), Southeast Asian (n=23), Middle Eastern (n=39) and other (n=2) patients and 107 rifampicin-susceptible isolates were tested. Mutations in rpoB were detected by DNA sequencing. Polymorphisms at katG463 and gyrA95 were detected by PCR-RFLP for genetic group assignment.

Results: None of rifampicin-susceptible but 116 of 119 rifampicin-resistant isolates showed rpoB mutation(s). Mutations among isolates from South Asian patients were distributed at rpoB516 (20%), rpoB526 (24%) and rpoB531 (27%) while 78 and 51 per cent of isolates from Southeast Asian and Middle Eastern patients, respectively, contained a mutated rpoB531. All isolates with rpoB N-terminal and cluster II mutations were obtained from Middle Eastern and South Asian patients. Most isolates from South Asian (84%) and Southeast Asian (70%) patients belonged to genetic group I while nearly all remaining isolates belonged to genetic group II. Isolates from Middle Eastern patients were distributed among genetic group I (46%), genetic group II (33%) and genetic group III (21%).

Interpretation & Conclusions: The occurrence of specific rpoB mutations varied considerably in rifampicin-resistant M. tuberculosis isolates obtained from patients of different ethnic groups within the same country. The present data have important implications for designing region-specific rapid methods for detecting majority of rifampicin-resistant strains.

Citing Articles

First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Kuwait and evaluation of REBA MTB-MDR assay for rapid detection of MDR-TB.

Al-Mutairi N, Ahmad S, Mokaddas E, Al-Hajoj S PLoS One. 2022; 17(10):e0276487.

PMID: 36264939 PMC: 9584360. DOI: 10.1371/journal.pone.0276487.


Emerging Status of Multidrug-Resistant Bacteria and Fungi in the Arabian Peninsula.

Borgio J, Rasdan A, Sonbol B, Alhamid G, Almandil N, AbdulAzeez S Biology (Basel). 2021; 10(11).

PMID: 34827138 PMC: 8614875. DOI: 10.3390/biology10111144.


The Spectrum of Spontaneous Rifampin Resistance Mutations in the Bacillus subtilis Gene Depends on the Growth Environment.

Leehan J, Nicholson W Appl Environ Microbiol. 2021; 87(22):e0123721.

PMID: 34495706 PMC: 8552901. DOI: 10.1128/AEM.01237-21.


Current Epidemiological Characteristics of Imported Malaria, Vector Control Status and Malaria Elimination Prospects in the Gulf Cooperation Council (GCC) Countries.

Iqbal J, Ahmad S, Sher A, Al-Awadhi M Microorganisms. 2021; 9(7).

PMID: 34361867 PMC: 8307262. DOI: 10.3390/microorganisms9071431.


Increasing prevalence of resistance to second-line drugs among multidrug-resistant Mycobacterium tuberculosis isolates in Kuwait.

Al-Mutairi N, Ahmad S, Mokaddas E Sci Rep. 2021; 11(1):7765.

PMID: 33833390 PMC: 8032671. DOI: 10.1038/s41598-021-87516-0.


References
1.
Heep M, Brandstatter B, Rieger U, Lehn N, Richter E, Rusch-Gerdes S . Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J Clin Microbiol. 2001; 39(1):107-10. PMC: 87688. DOI: 10.1128/JCM.39.1.107-110.2001. View

2.
Hwang H, Chang C, Chang L, Chang S, Chang Y, Chen Y . Characterization of rifampicin-resistant Mycobacterium tuberculosis in Taiwan. J Med Microbiol. 2003; 52(Pt 3):239-245. DOI: 10.1099/jmm.0.05045-0. View

3.
Mokrousov I, Narvskaya O, Otten T, Limeschenko E, Steklova L, Vyshnevskiy B . High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Antimicrob Agents Chemother. 2002; 46(5):1417-24. PMC: 127151. DOI: 10.1128/AAC.46.5.1417-1424.2002. View

4.
Ahmad S, Mokaddas E . The occurrence of rare rpoB mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait. Int J Antimicrob Agents. 2005; 26(3):205-12. DOI: 10.1016/j.ijantimicag.2005.06.009. View

5.
Sintchenko V, Chew W, Jelfs P, Gilbert G . Mutations in rpoB gene and rifabutin susceptibility of multidrug-resistant Mycobacterium tuberculosis strains isolated in Australia. Pathology. 1999; 31(3):257-60. DOI: 10.1080/003130299105089. View